Among the six validated DEGs, VSIG4, HSD11B1, and CASP5 were upregulated in both higher immune score and stromal score groups, and high expression of these genes harbored unfavorable OS compared with low expression groups, suggesting that higher expressions of these genes were predictive of less tumor purity and worse prognosis. This evidence concerns the gene CASP5 and neoplasm.